Log In
BCIQ
Print this Print this
 

PYN17

  Manage Alerts
Collapse Summary General Information
Company Phynova Group plc
DescriptionCompound composed of four plant extracts with antioxidant, immune modulation and liver protection properties
Molecular Target Unknown
Mechanism of ActionUnknown
Therapeutic Modality 
Latest Stage of DevelopmentPhase II
Standard IndicationHepatitis C virus (HCV)
Indication DetailsTreat chronic hepatitis C virus (HCV) infection
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today